Cancer cells infected with oncogenic HPV genotypes develop a series of immune evasion mechanisms; thus, several strategies have been investigated to tackle them by enhancing CD4+ and CD8+ T cell responses such as gene-based, protein-based, peptide-based and dendritic-cell-based vaccines [100]. This evidence concerns the gene CD8A and cancer.